Finance

Beta
Ask
Lists
543828:BOM
Sudarshan Pharma Industries Ltd
₹36.75
-0.62%
(-0.23) 1D
Jun 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543828...
Open
₹35.71
High
₹36.75
Low
₹35.14
Mkt. cap
9.17B
Avg. vol.
185.73K
Volume
384.00K
P/E ratio
37.89
52-wk high
₹38.00
52-wk low
₹18.50
EPS
₹0.97
No. of employees
60
Open
₹35.71
High
₹36.75
Low
₹35.14
Mkt. cap
9.17B
Avg. vol.
185.73K
Volume
384.00K
P/E ratio
37.89
52-wk high
₹38.00
52-wk low
₹18.50
EPS
₹0.97
No. of employees
60
News stories
From sources across the web
About Sudarshan Pharma Industries Ltd
CEO-
Employees60
Founded2008
Headquarters-
SectorSpeciality chemicals
Websitesudarshanpharma.com
Last report
Apr 30, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
2.21B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.45B
1.69B
1.68B
2.21B
Cost of goods sold
1.29B
1.52B
1.48B
1.90B
Cost of revenue
1.29B
1.52B
1.48B
1.90B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.84M
17.78M
19.74M
21.01M
Operating expense
58.86M
82.51M
102.47M
117.67M
Total operating expenses
1.35B
1.61B
1.58B
2.02B
Operating income
101.60M
83.02M
99.60M
191.06M
Other non operating income
12.07M
18.63M
15.18M
41.25M
EBT including unusual items
54.09M
42.28M
51.98M
157.04M
EBT excluding unusual items
54.09M
42.28M
51.98M
157.04M
Income tax expense
14.51M
3.56M
10.50M
43.12M
Effective tax rate
26.82%
8.41%
20.20%
27.46%
Other operating expenses
34.18M
55.72M
73.62M
85.73M
Net income
39.58M
41.83M
43.57M
107.26M
Net profit margin
2.73%
2.48%
2.59%
4.86%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-59.58M
-59.38M
-62.79M
-75.26M
Net interest expenses
-59.58M
-59.38M
-62.79M
-75.26M
Depreciation and amortization charges
8.84M
9.01M
9.11M
10.93M
EBITDA
104.17M
91.95M
102.17M
200.53M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer